Connection

Julian Schulze Zur Wiesch to Benzimidazoles

Back to Details
This is a "connection" page, showing publications Julian Schulze Zur Wiesch has written about Benzimidazoles.
Julian Schulze Zur Wiesch
Connection Strength
0.258
Benzimidazoles
  1. Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study. Lancet Infect Dis. 2017 02; 17(2):215-222.
    View in: PubMed
    Score: 0.130
  2. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01). Clin Infect Dis. 2016 11 15; 63(10):1320-1324.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.